FI875719L - Nya alkansulfonanilidderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. - Google Patents

Nya alkansulfonanilidderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. Download PDF

Info

Publication number
FI875719L
FI875719L FI875719A FI875719A FI875719L FI 875719 L FI875719 L FI 875719L FI 875719 A FI875719 A FI 875719A FI 875719 A FI875719 A FI 875719A FI 875719 L FI875719 L FI 875719L
Authority
FI
Finland
Prior art keywords
farmaceutiska
alkansulfonanilidderivat
blandningar
nya
foerfarande foer
Prior art date
Application number
FI875719A
Other languages
English (en)
Finnish (fi)
Other versions
FI875719A7 (fi
FI875719A0 (fi
Inventor
Masaaki Matsuo
Kiyoshi Tsuji
Nobukiyo Konishi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868631083A external-priority patent/GB8631083D0/en
Priority claimed from GB878712647A external-priority patent/GB8712647D0/en
Priority claimed from GB878724903A external-priority patent/GB8724903D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI875719A0 publication Critical patent/FI875719A0/fi
Publication of FI875719A7 publication Critical patent/FI875719A7/fi
Publication of FI875719L publication Critical patent/FI875719L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20—Quaternary compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI875719A 1986-12-31 1987-12-28 Nya alkansulfonanilidderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar. FI875719L (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB868631083A GB8631083D0 (en) 1986-12-31 1986-12-31 2'-phenoxyalkanesulfonanilide derivatives
GB878712647A GB8712647D0 (en) 1987-05-29 1987-05-29 2'-phenoxyalkanesulfonanilide derivatives
GB878724903A GB8724903D0 (en) 1987-10-23 1987-10-23 2-phenoxyalkanesulfonanilide derivatives

Publications (3)

Publication Number Publication Date
FI875719A0 FI875719A0 (fi) 1987-12-28
FI875719A7 FI875719A7 (fi) 1988-07-01
FI875719L true FI875719L (fi) 1988-07-01

Family

ID=27263273

Family Applications (1)

Application Number Title Priority Date Filing Date
FI875719A FI875719L (fi) 1986-12-31 1987-12-28 Nya alkansulfonanilidderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.

Country Status (15)

Country Link
US (1) US4866091A (cs)
EP (1) EP0273369B1 (cs)
KR (1) KR910008138B1 (cs)
CN (1) CN87108295A (cs)
AR (1) AR243499A1 (cs)
AU (1) AU600782B2 (cs)
DE (1) DE3777122D1 (cs)
DK (1) DK693587A (cs)
ES (1) ES2033292T3 (cs)
FI (1) FI875719L (cs)
GR (1) GR3004051T3 (cs)
HU (1) HU200322B (cs)
IL (1) IL84913A0 (cs)
NO (1) NO168299C (cs)
PT (1) PT86407B (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL86462A (en) * 1987-05-29 1992-12-01 Fujisawa Pharmaceutical Co Alkanesulfonanilide derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same
JPH0753725B2 (ja) * 1987-10-08 1995-06-07 富山化学工業株式会社 ４ｈ―１―ベンゾピラン―４―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤
FI911633L (fi) * 1990-04-27 1991-10-28 Fujisawa Pharmaceutical Co Foerfarande foer framstaellning av alkansulfonanilidderivat.
ES2089546T3 (es) * 1991-08-08 1996-10-01 Taisho Pharmaceutical Co Ltd Compuesto 5-aminosulfonanilida.
AU661906B2 (en) * 1992-06-12 1995-08-10 Taisho Pharmaceutical Co., Ltd. 5-amino-2-phenoxysulfonanilide compound
US5604260A (en) * 1992-12-11 1997-02-18 Merck Frosst Canada Inc. 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2
AU4479096A (en) * 1995-01-31 1996-08-21 Merck Frosst Canada Inc. 5-methanesulfonamido-3h-isobenzofuran-1-ones as inhibitors of cyclooxygenase-2
US5681842A (en) * 1996-11-08 1997-10-28 Abbott Laboratories Prostaglandin synthase-2 inhibitors
KR20010020201A (ko) 1997-04-22 2001-03-15 코센시스 인크 탄소고리 및 헤테로고리 치환된 세미카르바존 및 티오세미카르바존과 그들의 사용 방법
ES2158809B1 (es) * 1999-10-18 2002-03-16 Menarini Lab Nuevos derivados sulfonados como inhibidores de la ciclooxigenasa ii.
BRPI0411275A (pt) * 2003-06-10 2006-08-01 Kalypsys Inc compostos de carbonila como inibidores de histona deacetilase para tratamento de doenças; composição farmacêutica; método de modular a atividade catalìtica de hdac; método de tratar doença em um indivìduo; utilização de um composto ou composição; método de inibir hdac
WO2005123089A2 (en) 2004-06-10 2005-12-29 Kalypsys, Inc. Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
CN102741226B (zh) * 2009-10-30 2016-01-06 詹森药业有限公司 4-取代的-2-苯氧基-苯胺δ阿片类受体调节剂
JP6484555B2 (ja) * 2013-08-29 2019-03-13 京都薬品工業株式会社 新規芳香族化合物およびその用途
CN109912434B (zh) * 2017-12-13 2022-07-12 上海安谱实验科技股份有限公司 苯乙醇胺类β受体激动剂的合成方法
CN109608370A (zh) * 2019-01-22 2019-04-12 山西康斯亚森生物科技有限公司 尼美舒利衍生物和制备方法及用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3531522A (en) * 1967-07-18 1970-09-29 Upjohn Co 4'-phenoxyalkanesulfonanilides
US3531523A (en) * 1967-07-18 1970-09-29 Upjohn Co N-(phenoxyphenyl)sulfamides
US3906024A (en) * 1971-02-24 1975-09-16 Minnesota Mining & Mfg Perfluoroalkanesulfonamidoaryl compounds
US3840597A (en) * 1971-02-24 1974-10-08 Riker Laboratories Inc Substituted 2-phenoxy alkane-sulfonanilides
AR206496A1 (es) * 1972-07-03 1976-07-30 Riker Laboratories Inc Procedimiento para la preparacion de 2-fenoxi-4-nitro-alquil o haloalquilsulfonanilidas
US4465508A (en) * 1979-07-18 1984-08-14 Imperial Chemical Industries Plc Diphenyl ether herbicides
DE3114072A1 (de) * 1981-04-08 1982-11-04 Basf Ag, 6700 Ludwigshafen Herbizide diphenylether, deren herstellung und verwendung als herbizide
DE3466979D1 (en) * 1983-12-16 1987-12-03 Ciba Geigy Ag Process for the protection of keratinic material against the attack of keratin eating insects and phenoxytrifluoromethane sulfonanilides

Also Published As

Publication number Publication date
GR3004051T3 (cs) 1993-03-31
NO168299B (no) 1991-10-28
HU200322B (en) 1990-05-28
NO875488D0 (no) 1987-12-30
CN87108295A (zh) 1988-07-13
EP0273369A3 (en) 1989-10-18
DK693587A (da) 1988-07-01
HUT45971A (en) 1988-09-28
KR880007447A (ko) 1988-08-27
ES2033292T3 (es) 1993-03-16
FI875719A7 (fi) 1988-07-01
FI875719A0 (fi) 1987-12-28
AU600782B2 (en) 1990-08-23
DE3777122D1 (de) 1992-04-09
KR910008138B1 (ko) 1991-10-10
EP0273369A2 (en) 1988-07-06
AR243499A1 (es) 1993-08-31
NO875488L (no) 1988-07-01
US4866091A (en) 1989-09-12
DK693587D0 (da) 1987-12-30
AU8315287A (en) 1988-07-07
IL84913A0 (en) 1988-06-30
NO168299C (no) 1992-02-05
PT86407A (en) 1988-01-01
PT86407B (pt) 1990-11-20
EP0273369B1 (en) 1992-03-04

Similar Documents

Publication Publication Date Title
FI880546A7 (fi) Nya kolfibriller, foerfarande foer framstaellning daerav och kompositioner innehaollande desamma.
FI873142A7 (fi) Nya benzolsulfonamido -indanylfoereningar, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI860971A0 (fi) Nya sulfonylaminoetylfoereningar, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI886005A7 (fi) Nya, sulfhydrylgrupper innehaollande tricykliska laktamer och deras farmakologiska anvaendningsfoerfaranden.
FI892454L (fi) Nya bensimidazolderivat, foerfarande foer framstaellning av desamma och farmaceutisk komposition innehaollande desamma.
FI875727L (fi) Nya oligosackarider, immunogener och vacciner och foerfarande foer framstaellning av saodana oligosackarider, immunogener och vacciner.
FI874323A0 (fi) Nya imidazo-benzoxazinoner, deras framstaellning och dessa foereningar innehaollande laekemedel.
FI872841A0 (fi) Nya kromoforfoereningar, solskyddskompositioner och foerfarande foer hindrande av solbraenna.
FI870274A0 (fi) Nya alkan- och alkoxialkanderivat, foerfarande foer deras framstaellning och dessa foereningar innehaollande bekaempningsmedel foer insekter och kvalster.
FI871052A7 (fi) Nya substituerade tiazoler och oxazoler, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI883347A0 (fi) Nya 5-aminometylen-2,4 -imidazolidindioner och 5-aminometylen-4-tionoimidazolidin-4-oner.
FI882385L (fi) Fosforhaltiga hmg-coa -reduktasinhibitorer, foerfarande foer framstaellning daerav och nya mellanprodukter.
FI875719A0 (fi) Nya alkansulfonanilidderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI885811L (fi) Nya ammoniumfoereningar, deras framstaellning och anvaendning.
FI882477A7 (fi) Nya alkansulfonanilidderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI875595A7 (fi) Nya bicykliska difosfonatfoereningar, farmaceutiska kompositioner och foerfarande foer behandling av avvikande kalcium- och fosfatmetabolism.
FI881816L (fi) Nya bicykliska foereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI873934A7 (fi) Nya naftylderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI875086A7 (fi) Nya benzotiadiazinfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI873917A7 (fi) Nya naftalin- och indanderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI873243A0 (fi) Nya 1,4-benzodiazepiner, deras framstaellning och anvaendning.
FI873783A7 (fi) Nya sulfonamido-etylfoereningar, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI885056L (fi) Nya fluormetoxifenyldihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
FI872635A7 (fi) Nya polypeptider, deras framstaellning och anvaendning.
FI883745A7 (fi) Nya kondenserade diazepinoner, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO., LTD.